Kestra Medical Technologies’ (KMTS) “Buy” Rating Reiterated at BTIG Research
BTIG Research reiterated their buy rating on shares of Kestra Medical Technologies (NASDAQ:KMTS – Free Report) in a report published on Wednesday,Benzinga reports. The firm currently has a $32.00 price target on the stock. KMTS has been the topic of several other research reports. Piper Sandler raised their price objective on Kestra Medical Technologies from […]
21 Mar 07:46 · The Markets Daily